Sidoti Csr Predicts Balchem’s FY2024 Earnings (NASDAQ:BCPC)

Balchem Co. (NASDAQ:BCPC) – Stock analysts at Sidoti Csr upped their FY2024 earnings per share (EPS) estimates for Balchem in a report released on Monday, October 28th. Sidoti Csr analyst K. May now expects that the basic materials company will post earnings of $4.36 per share for the year, up from their prior forecast of $4.11. The consensus estimate for Balchem’s current full-year earnings is $3.96 per share. Sidoti Csr also issued estimates for Balchem’s Q4 2024 earnings at $1.11 EPS.

BCPC has been the subject of a number of other reports. StockNews.com raised Balchem from a “hold” rating to a “buy” rating in a report on Monday. HC Wainwright boosted their price target on Balchem from $170.00 to $185.00 and gave the stock a “buy” rating in a report on Wednesday, July 31st.

Balchem Stock Performance

NASDAQ BCPC opened at $169.26 on Tuesday. Balchem has a fifty-two week low of $113.90 and a fifty-two week high of $186.03. The stock has a market cap of $5.49 billion, a price-to-earnings ratio of 47.81, a price-to-earnings-growth ratio of 5.43 and a beta of 0.65. The business has a fifty day moving average of $171.75 and a 200-day moving average of $162.70. The company has a quick ratio of 1.79, a current ratio of 2.83 and a debt-to-equity ratio of 0.26.

Institutional Investors Weigh In On Balchem

Several institutional investors and hedge funds have recently added to or reduced their stakes in the company. Conestoga Capital Advisors LLC increased its stake in Balchem by 1.8% during the third quarter. Conestoga Capital Advisors LLC now owns 1,175,569 shares of the basic materials company’s stock worth $206,900,000 after acquiring an additional 20,360 shares during the last quarter. Congress Asset Management Co. increased its stake in Balchem by 12.4% during the third quarter. Congress Asset Management Co. now owns 301,440 shares of the basic materials company’s stock worth $53,053,000 after acquiring an additional 33,373 shares during the last quarter. First Trust Direct Indexing L.P. increased its stake in Balchem by 12.5% during the third quarter. First Trust Direct Indexing L.P. now owns 1,589 shares of the basic materials company’s stock worth $280,000 after acquiring an additional 177 shares during the last quarter. Argent Capital Management LLC increased its stake in Balchem by 15.3% during the third quarter. Argent Capital Management LLC now owns 4,185 shares of the basic materials company’s stock worth $737,000 after acquiring an additional 556 shares during the last quarter. Finally, Private Advisor Group LLC acquired a new stake in Balchem during the third quarter worth about $220,000. 87.91% of the stock is currently owned by institutional investors and hedge funds.

About Balchem

Balchem Corporation develops, manufactures, and markets specialty performance ingredients and products for the nutritional, food, pharmaceutical, animal health, medical device sterilization, plant nutrition, and industrial markets worldwide. It operates through three segments: Human Nutrition and Health, Animal Nutrition and Health, and Specialty Products.